Lujan-Mendez F, Garcia-Lopez P, Berumen L, Garcia-Alcocer G, Ferriz-Martinez R, Ramirez-Carrera A
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006027
PMC: 11858825.
DOI: 10.3390/ph18020213.
Iluta S, Nistor M, Buruiana S, Dima D
Life (Basel). 2025; 15(2).
PMID: 40003637
PMC: 11856057.
DOI: 10.3390/life15020228.
Liu L, Han F, Deng M, Han Q, Lai M, Zhang H
Cell Death Differ. 2025; .
PMID: 39870803
DOI: 10.1038/s41418-025-01450-6.
Filippi A, Deculescu-Ionita T, Hudita A, Baldasici O, Galateanu B, Mocanu M
Int J Mol Sci. 2025; 26(2).
PMID: 39859345
PMC: 11766403.
DOI: 10.3390/ijms26020631.
Zhou L, Min Y, Cao Q, Tan X, Cui Y, Wang J
Biofactors. 2024; 51(1):e2155.
PMID: 39704033
PMC: 11659921.
DOI: 10.1002/biof.2155.
Leucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling.
Rathore M, Curry K, Huang W, Wright M, Martin D, Baek J
Gastroenterology. 2024; 168(2):300-315.e3.
PMID: 39393543
PMC: 11769768.
DOI: 10.1053/j.gastro.2024.10.004.
Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance.
Niharika , Garg M
Expert Rev Mol Med. 2024; 26:e23.
PMID: 39375840
PMC: 11488345.
DOI: 10.1017/erm.2024.23.
NRF2 signaling plays an essential role in cancer progression through the NRF2-GPX2-NOTCH3 axis in head and neck squamous cell carcinoma.
Jin X, Lou X, Qi H, Zheng C, Li B, Siwu X
Oncogenesis. 2024; 13(1):35.
PMID: 39333079
PMC: 11437035.
DOI: 10.1038/s41389-024-00536-z.
Targeting the tumour vasculature: from vessel destruction to promotion.
Guelfi S, Hodivala-Dilke K, Bergers G
Nat Rev Cancer. 2024; 24(10):655-675.
PMID: 39210063
DOI: 10.1038/s41568-024-00736-0.
Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma.
Kerdkumthong K, Roytrakul S, Songsurin K, Pratummanee K, Runsaeng P, Obchoei S
Biomolecules. 2024; 14(8).
PMID: 39199357
PMC: 11352417.
DOI: 10.3390/biom14080969.
Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression.
Tayanloo-Beik A, Eslami A, Sarvari M, Jalaeikhoo H, Rajaeinejad M, Nikandish M
Oncol Rev. 2024; 18:1411736.
PMID: 39091989
PMC: 11291337.
DOI: 10.3389/or.2024.1411736.
Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.
Li X, Zhang C, Yue W, Jiang Y
Front Immunol. 2024; 15:1362120.
PMID: 38962016
PMC: 11219812.
DOI: 10.3389/fimmu.2024.1362120.
Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.
Pandya P, Al-Qasrawi D, Klinge S, Justilien V
Front Immunol. 2024; 15:1369356.
PMID: 38765006
PMC: 11099288.
DOI: 10.3389/fimmu.2024.1369356.
Vessel co-option: a unique vascular-immune niche in liver cancer.
Yang D, Dang S, Wang Z, Xie M, Li X, Ding X
Front Oncol. 2024; 14:1386772.
PMID: 38737903
PMC: 11082301.
DOI: 10.3389/fonc.2024.1386772.
Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy.
Yang K, Yi T
Front Mol Biosci. 2024; 10:1297611.
PMID: 38455361
PMC: 10918437.
DOI: 10.3389/fmolb.2023.1297611.
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting.
Guo Q, Zhou Y, Xie T, Yuan Y, Li H, Shi W
Genes Dis. 2024; 11(3):101043.
PMID: 38292177
PMC: 10825311.
DOI: 10.1016/j.gendis.2023.05.024.
The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy.
Carrera-Aguado I, Marcos-Zazo L, Carrancio-Salan P, Guerra-Paes E, Sanchez-Juanes F, Munoz-Felix J
Int J Mol Sci. 2024; 25(2).
PMID: 38255995
PMC: 10815934.
DOI: 10.3390/ijms25020921.
Soluble and multivalent Jag1 DNA origami nanopatterns activate Notch without pulling force.
Smyrlaki I, Fordos F, Rocamonde-Lago I, Wang Y, Shen B, Lentini A
Nat Commun. 2024; 15(1):465.
PMID: 38238313
PMC: 10796381.
DOI: 10.1038/s41467-023-44059-4.
Endothelial cells metabolically regulate breast cancer invasion toward a microvessel.
Tan M, Jenkins-Johnston N, Huang S, Schutrum B, Vadhin S, Adhikari A
APL Bioeng. 2023; 7(4):046116.
PMID: 38058993
PMC: 10697723.
DOI: 10.1063/5.0171109.
Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models.
Wang Q, Zhang Y, Li C, Wang Y, Wu L, Wang X
Aging (Albany NY). 2023; 15(23):13799-13821.
PMID: 38054820
PMC: 10756133.
DOI: 10.18632/aging.205263.